Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 14 04:00PM ET
1.18
Dollar change
+0.13
Percentage change
12.38
%
Index- P/E- EPS (ttm)-0.72 Insider Own1.91% Shs Outstand23.95M Perf Week15.69%
Market Cap28.26M Forward P/E- EPS next Y-0.35 Insider Trans0.00% Shs Float23.50M Perf Month-15.11%
Income-8.05M PEG- EPS next Q-0.09 Inst Own1.38% Short Float0.26% Perf Quarter-10.61%
Sales0.00M P/S- EPS this Y66.67% Inst Trans1.21% Short Ratio1.43 Perf Half Y48.24%
Book/sh0.10 P/B11.26 EPS next Y-6.06% ROA-172.23% Short Interest0.06M Perf Year-41.00%
Cash/sh0.18 P/C6.44 EPS next 5Y- ROE-320.57% 52W Range0.53 - 3.29 Perf YTD-48.47%
Dividend Est.- P/FCF- EPS past 5Y-22.39% ROI-455.63% 52W High-64.13% Beta1.02
Dividend TTM- Quick Ratio1.54 Sales past 5Y0.00% Gross Margin- 52W Low122.39% ATR (14)0.12
Dividend Ex-Date- Current Ratio1.54 EPS Y/Y TTM35.11% Oper. Margin0.00% RSI (14)49.45 Volatility15.21% 9.22%
Employees8 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price3.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q79.91% Payout- Rel Volume2.04 Prev Close1.05
Sales Surprise- EPS Surprise46.15% Sales Q/Q- EarningsMay 13 Avg Volume42.92K Price1.18
SMA20-1.99% SMA50-4.13% SMA200-4.81% Trades Volume88,267 Change12.38%
Jun-10-24 08:30AM
May-30-24 08:30AM
May-21-24 09:00AM
May-14-24 09:00AM
May-13-24 09:53AM
09:00AM Loading…
May-02-24 09:00AM
Apr-18-24 08:30AM
Apr-16-24 08:30AM
Apr-15-24 08:00AM
Apr-08-24 01:52PM
08:30AM
Apr-05-24 08:30AM
Mar-12-24 09:00AM
Mar-08-24 04:05PM
Feb-06-24 08:30AM
08:30AM Loading…
Jan-29-24 08:30AM
Dec-21-23 08:30AM
Dec-19-23 08:30AM
Dec-13-23 08:31AM
Nov-16-23 08:35AM
Nov-14-23 08:30AM
Oct-02-23 08:30AM
Aug-17-23 08:30AM
Jul-31-23 08:30AM
Jul-20-23 08:00AM
Jun-29-23 11:42AM
08:00AM
Jun-20-23 08:30AM
Jun-12-23 08:30AM
Jun-01-23 08:30AM
08:30AM Loading…
May-25-23 08:30AM
May-24-23 08:30AM
May-15-23 08:30AM
May-01-23 08:30AM
Apr-28-23 08:30AM
Apr-27-23 08:30AM
Apr-14-23 08:30AM
Apr-11-23 08:30AM
Mar-30-23 12:20PM
08:30AM
Mar-22-23 09:00AM
Mar-08-23 12:26PM
08:30AM
Mar-03-23 10:00AM
Mar-02-23 08:30AM
Mar-01-23 08:30AM
Jan-25-23 08:30AM
Jan-18-23 12:31PM
08:30AM
Jan-11-23 10:43AM
Jan-05-23 08:30AM
Dec-15-22 08:30AM
Nov-17-22 08:30AM
Nov-14-22 08:30AM
Oct-21-22 08:30AM
Oct-04-22 08:00AM
Sep-28-22 08:30AM
Sep-19-22 08:30AM
Sep-07-22 08:00AM
Aug-15-22 08:00AM
Aug-04-22 10:48AM
Jul-19-22 08:30AM
Jul-13-22 08:00AM
Jun-09-22 08:30AM
Jun-02-22 08:30AM
May-19-22 08:30AM
May-18-22 08:00AM
May-16-22 07:30AM
Mar-30-22 08:30AM
Mar-11-22 08:30AM
Feb-22-22 08:00AM
Feb-03-22 09:29AM
Jan-19-22 08:00AM
Jan-06-22 08:00AM
Nov-26-21 06:28AM
Nov-15-21 04:15PM
Nov-11-21 06:00AM
Nov-10-21 10:13AM
09:44AM
07:25AM
06:52AM
Nov-09-21 06:00AM
Sep-07-21 02:32PM
06:24AM
06:00AM
Aug-30-21 12:15PM
Aug-27-21 07:08AM
Aug-15-21 11:05AM
RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in December 2009 and is headquartered in Los Altos, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nelms AngelaChief Operating OfficerOct 03 '23Buy1.051,1001,1511,100Oct 04 04:44 PM